Global Vaccine Market predicted to be US$ 70 Billion by 2024

Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, End User, Companies

Global Vaccine Market & Forecast Analyst View: Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024.

Press Release Title: Global Vaccine Market predicted to be US$ 70 Billion by 2024.

For more Info: https://www.renub.com/global-vaccines-market-to-be-an-opportunityof-more-than-us-60-billion-58-nd.php Report Title: Global Vaccine Market, People Vaccinated, Vaccines Administered, Immunization, By Disease [Influenza, Cervical Cancer, Zoster (Shingles), MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilus influenzae type B (Hib), Polio, Rotavirus, Varicella, Combination Vaccine, Travel & Miscellaneous Vaccine],

By End User [Infants (Pediatric), & Adult], Companies (GlaxoSmithKline, Merck, Sanofi, Pfizer, & Others)

Access Full Research: https://www.renub.com/global-vaccines-market-and-forecast-14vaccines-market-number-of-people-immunized-doses-of-vaccinesadministered-1200-p.php Š Renub Research

Page 1 of 7

www.renub.com

Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, End User, Companies

Get Free Customization in this Report According to Renub Research latest report on Vaccine industry Global Vaccine Market around the world would be US$ 70 Billion by the year 2024. Vaccine is considered as one of the best quality science across all streams pertinent in the field of Vaccinology. Vaccines are derived from the killed or inactivated pathogens, which are unable to cause any sickness to vaccinated people.

When a person is vaccinated, it is impracticable for them to become sick with that particular disease. Early vaccination and the completion of complete vaccination schedule among the infants to their adulthood, helps reduce the prevalence of vaccine preventable diseases and its burden across the countries around the world.

Request a free sample copy of the report: https://www.renub.com/contactus.php Vaccination is one of the best ways to protect infants, teens and elderly from almost 16 potentially harmful diseases which can be very fatal and may require hospitalization or even be deadly. Many people think that immunizations are just for infants while childhood vaccinations can wear off over a period of time and hence, adults may also be at serious risk of developing vaccine preventable diseases due to change in lifestyle, age and health conditions.

Today, vaccination has helped to reduce the global burden of a range of viral and bacterial diseases around the world. Vaccination against the particular disease not only limits the incidence of that disease, but it also minimizes the socioeconomic burden of that disease in the society. An appropriate rate of immunization can lead to the substantial blocking of transmission for several vaccine preventable diseases. Today, the world has witnessed the eradication of smallpox and is near to the elimination of polio from most countries across the world due to the role of immunization in controlling disease.

List of some of the vaccine Preventable diseases include: • • • • • • • • • • • • • •

Diphtheria Pertussis (whooping cough) MMR (Measles, Mumps and Rubella) Polio (poliomyelitis) Haemophilus Influenzae type b infections (Hib) Influenza Hepatitis Pneumococcal infections Meningococcal disease Varicella-zoster (chickenpox) Human papillomavirus (Cervical Cancer) Tetanus Yellow fever Japanese encephalitis

© Renub Research

Page 2 of 7

www.renub.com

Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, End User, Companies

How do Vaccines Work?

Vaccines work is to prime one’s immune system against future attacks by a specific disease.

There are vaccines that work against both bacterial and viral pathogens and disease causing agents. When a pathogen enters in the immunized person’s body, the person’s immune system generates antibodies to fight it off. Depending upon the strength of one’s immune response and how effectively the antibodies scrap off the pathogen, one may or may not get ill.

Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/global-vaccines-market-and-forecast-14-vaccines-marketnumber-of-people-immunized-doses-of-vaccines-administered-1200-p.php

When a person is vaccinated with whatever the version of a pathogen that vaccine contains, the vaccination isn’t so strong to make them sick, but it has enough for one’s immune system to develop resistance against the particular pathogen. As a result, the person gets future immunity against the disease without getting ill; if when exposed to the pathogen.

Today, with increasing community awareness regarding the benefits of vaccines against vaccine preventable diseases, increasing government role in strengthening immunization programs and increasing funding from several governments and non-governments sectors certainly help boost Global Vaccines Market in the near future.

© Renub Research

Page 3 of 7

www.renub.com

Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, End User, Companies

Key Topics Covered 1.

Research Findings

2.

Global – Vaccines Market and Forecast 2.1 2.2

Adult Vaccines Market Pediatric (Infant) Vaccines Market

3.

Global – Adult Vaccine vs. Pediatric Vaccine Market Share

4.

Global – Vaccines Market Share and Forecast 4.1 4.2

5.

Global – Vaccinated People 5.1 5.2

6.

10.

Doses of Adult Vaccines Administered Doses of Infant (Pediatric) Vaccines Administered

Global – Doses of Vaccines Administered Share 8.1 8.2

9.

Vaccinated Adult Share Vaccinated Infant (Pediatric) Share

Global – Doses of Vaccines Administered and Forecast 7.1 7.2

8.

Adult Immunized and Forecast Vaccinated Infant (Pediatric)

Global – Vaccinated People Share 6.1 6.2

7.

Adult Vaccines Market Share Pediatric (Infant) Vaccines Market Share

Doses of Vaccines Administered to Adult Share Doses of Vaccines Administered to Infant (Pediatric) Share

Global – Vaccine Companies Market Share and Forecast Disease wise – Vaccines Market and Forecast 10.1

Influenza – Total Vaccines Market

10.2

Cervical Cancer (HPV) – Vaccines Market

10.3

Zoster (Shingles) – Vaccines Market

10.4

MMR (Measles, Mumps, and Rubella Vaccine) – Total Vaccines Market

10.5

Pneumococcal – Total Vaccines Market

10.6

Meningococcal – Total Vaccines Market

10.7

Hepatitis – Total Vaccines Market

10.8

TdaP and DTaP – Total Vaccines Market

10.9

Travel and Miscellaneous – Vaccines Market

10.10

Haemophilus Influenzae Type B (HIB) – Vaccines Market

© Renub Research

Page 4 of 7

www.renub.com

Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, End User, Companies

11.

12.

10.11

Combos (Combination) – Vaccines Market

10.12

Polio – Vaccines Market

10.13

Rotavirus – Vaccines Market

10.14

Varicella – Vaccines Market

Disease wise – Numbers of Vaccinated People & Forecast 11.1

Influenza – Total Number of Vaccinated People

11.2

Cervical Cancer (HPV) – Number of Vaccinated People

11.3

Zoster (Shingles) – Number of Vaccinated People

11.4

MMR – Total Number of Vaccinated People

11.5

Pneumococcal – Total Number of Vaccinated People

11.6

Meningococcal – Total Number of Vaccinated People

11.7

Hepatitis – Total Number of Vaccinated People

11.8

TdaP and DTaP – Total Number of Vaccinated People

11.9

Hib (Haemophilus Influenzae Type B) – Number of Vaaccinated Infants

11.10

Combos (Combination Vaccines) – Number of Vaccinated Infants

11.11

Polio – Number of Infants Immunized and Forecast

11.12

Rotavirus – Number of Vaccinated Infants

11.13

Varicella – Total Number of Vaccinated People

Disease wise – Doses of Vaccines Administered and Forecast 12.1

Influenza – Doses of Vaccines Administered

12.2

Cervical Cancer (HPV) – Doses of Vaccines Administered

12.3

Zoster (Shingles) – Doses of Vaccines Administered

12.4

MMR – Doses of Vaccines Administered

12.5

Pneumococcal – Doses of Vaccines Administered

12.6

Meningococcal – Doses of Vaccines Administered

12.7

Hepatitis – Doses of Vaccines Administered

12.8

TdaP and DTaP – Doses of Vaccines Administered

12.9 Hib (Haemophilus Influenzae Type B) – Doses of Infant Vaccines Administered and Forecast 12.10

Polio – Doses of Infant Vaccines Administered

12.11

Rotavirus – Doses of Infant Vaccines Administered and Forecast

12.12

Varicella – Doses of Vaccines Administered

© Renub Research

Page 5 of 7

www.renub.com

Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, End User, Companies 13.

14.

15.

Disease wise - Immunization Profile 13.1

Immunization Coverage (%) in Infants

13.2

Global Immunization Profile

13.3

Regional Immunization Profile

Vaccines Key Players Sales and Forecast 14.1

GlaxoSmithKline, plc.’s Vaccines Sales

14.2

Merck & Co. Vaccines Sales

14.3

Sanofi Pasteur’s Vaccines Sales

14.4

Pfizer, Inc.’s Vaccines Sales

14.5

Global – Other Companies Vaccines Sales

Vaccines – Products and Pipeline 15.1

GSK Vaccine Product Pipeline

15.2

Merck Vaccine Product Pipeline

15.3

Sanofi Vaccine Product Pipeline

15.4

Pfizer Vaccine Product Pipeline

16.

Top Mergers and Acquisitions in the Vaccine Industry

17.

Vaccines and Regulator’s Interventions

18.

17.1

Making and Meeting Standards of Quality and Safety

17.2

Vaccine Funding

Vaccine Market Drivers 18.1

Inclusion in National Immunization Schedule

18.2

Growing Immunization Coverage for HPV Vaccines

18.3

Increase in Prevalence of Infectious Diseases

18.4

Global Immunization Vision and Strategy (GIVS)

18.5

GAVI Model Fuelling Vaccine Manufacturers

18.6

Increasing Vaccine Availability in United States

18.7

The Vaccine Safety Data link Project

18.8

The Vaccine Injury Compensation Program

18.9

Transforming of Vaccine Technologies

18.10

Global Vaccine Action Plan by WHO (2011 - 2020)

18.11

Continuous Focus on Effective Communication Strategies

© Renub Research

Page 6 of 7

www.renub.com

Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, End User, Companies 19.

Vaccines Market Challenges 19.1

Hurdles to Optimal use of Licensed Vaccines

19.2 Complexity of Vaccine Development & Approval System Thwarts Product Development 19.3

Shortening the Timeline for Vaccine Development

19.4

Refusal/Resistance to Vaccination

19.4.1

Vaccine Adverse Event Reporting System

19.5

Vaccine Shortages and Delays

19.6

Obstacles in Vaccine Research & Development

19.7

Barriers to New Entrants in the Vaccines Market

Vaccines Market Reports:

https://www.renub.com/vaccines-12-c.php

Renub Research - North America

Renub Research - Asia

Rajat Gupta

Ankit Mishra

225 Kristie Ln, Roswell

C – 86, Sector – 10

Georgia 30076, United States

Noida 201301, India

Tel: +1-678-302-0700

Tel: +91-120-421-9822

Email: info@renub.com

Email: info@renub.com

https://www.renub.com/

https://www.renub.com/

© Renub Research

Page 7 of 7

www.renub.com